These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10496663)

  • 21. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
    Milne M; Liebenberg W; Aucamp M
    AAPS PharmSciTech; 2015 Oct; 16(5):1190-202. PubMed ID: 25732372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
    Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
    Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 1. Nedocromil magnesium.
    Zhu H; Khankari RK; Padden BE; Munson EJ; Gleason WB; Grant DJ
    J Pharm Sci; 1996 Oct; 85(10):1026-34. PubMed ID: 8897266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine.
    Li Y; Han J; Zhang GG; Grant DJ; Suryanarayanan R
    Pharm Dev Technol; 2000; 5(2):257-66. PubMed ID: 10810755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of protein on mannitol polymorphic form produced during co-spray drying.
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dehydration of raffinose pentahydrate: structures of raffinose 5-, 4.433-, 4.289- and 4.127-hydrate at 93 K.
    Viriyarattanasak C; Shiro M; Munekawa S; Franks F; Ikeda S; Kajiwara K
    Acta Crystallogr C Struct Chem; 2015 Nov; 71(Pt 11):954-8. PubMed ID: 26524166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro simulation of solid-solid dehydration, rehydration, and solidification of trehalose dihydrate using thermal and vibrational spectroscopic techniques.
    Lin SY; Chien JL
    Pharm Res; 2003 Dec; 20(12):1926-31. PubMed ID: 14725355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation.
    Miller DP; Tan T; Nakamura J; Malcolmson RJ; Tarara TE; Weers JG
    Mol Pharm; 2017 Jun; 14(6):1950-1960. PubMed ID: 28418683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
    Sovago I; Wang W; Qiu D; Raijada D; Rantanen J; Grohganz H; Rades T; Bond AD; Löbmann K
    Molecules; 2016 Apr; 21(4):509. PubMed ID: 27104502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydration of risedronate hemi-pentahydrate: analytical and physical characterization.
    Lester C; Lubey G; Dicks M; Andol G; Vaughn D; Cambron RT; Poiesz K; Redman-Furey N
    J Pharm Sci; 2006 Dec; 95(12):2631-44. PubMed ID: 16917848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound.
    Kuang S; Shah HS; Zhao B
    Pharm Res; 2024 Jul; 41(7):1533-1541. PubMed ID: 38872035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of dehydration and hydration behavior of calcium lactate pentahydrate and its anhydrate.
    Sakata Y; Shiraishi S; Otsuka M
    Colloids Surf B Biointerfaces; 2005 Dec; 46(3):135-41. PubMed ID: 16293401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties and stability of a liquid crystal form of cyclosporine-the first reported naturally occurring peptide that exists as a thermotropic liquid crystal.
    Lechuga-Ballesteros D; Abdul-Fattah A; Stevenson CL; Bennett DB
    J Pharm Sci; 2003 Sep; 92(9):1821-31. PubMed ID: 12950000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
    Kushida I; Gotoda M
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
    Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
    J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
    Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical characterization of picotamide monohydrate and anhydrous picotamide.
    Bettinetti G; Mura P; Sorrenti M; Faucci MT; Negri A
    J Pharm Sci; 1999 Nov; 88(11):1133-9. PubMed ID: 10564061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.